ACET - Adicet Bio, Inc.
7.57
0.550 7.266%
Share volume: 135,962
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$7.02
0.55
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-06-2024 | 03-06-2025 | 05-06-2025 | 08-07-2025 | 11-05-2025 | |
| Cash flow financing | 110.966 M | 204.000 K | 0.000 | 137.000 K | -104.000 K | 267.000 K | -150.000 K | |
| Other financing cash flows | 48.000 K | 6.000 K | 0.000 | 0.000 | -104.000 K | 0.000 | -150.000 K | |
| Cash flow | 87.878 M | -23.520 M | 0.000 | -46.084 M | -28.362 M | 6.587 M | -5.621 M | |
| Net income | -28.016 M | -29.901 M | -30.478 M | 0.000 | -28.214 M | -31.217 M | -26.856 M | |
| Depreciation | 1.651 M | 1.602 M | 1.592 M | 1.623 M | 1.680 M | 1.655 M | 1.573 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -239.000 K | -302.000 K | -96.581 M | -22.120 M | -2.861 M | 32.953 M | 16.836 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 87.878 M | -23.520 M | -118.587 M | -46.084 M | -28.362 M | 6.587 M | -5.621 M |